In a new study, scientists found that the extract was effective against coronaviruses and enteroviruses, for which there is currently no cure.
Finnish researchers found that willow bark extract, known for its medicinal properties including the basis of aspirin, has a broad-spectrum antiviral effect. Phys.org writes that this result opens up the possibility of its use in the treatment of various viral infections.
Focus.Technology has its own technology. telegram channel. Subscribe to avoid missing the latest and most exciting news from the world of science!
A study led by Professor Varpu Marjomäki from the University of Jyväskylä found that the extract was effective against both enveloped coronaviruses that cause the common cold and COVID-19, and non-enveloped enteroviruses that cause diseases such as influenza and meningitis. . In particular, there is currently no specific drug directed against enteroviruses, highlighting the potential importance of this discovery.
During the research, experts collected willow bark, processed it into an extract and tested it against various viruses. The extract was found to effectively inhibit viral activity without harming host cells. Interestingly, while the extract prevented the proliferation of Covid-19 in cells, it had a different effect on enteroviruses, completely preventing them from penetrating the cells.
This different effect shows that willow bark extract acts on the surface of viruses with different effects. Microscopic examination showed that enveloped coronaviruses were destroyed by the extract, while non-enveloped enteroviruses were effectively immobilized.
Additionally, when investigating the effectiveness of commercial compounds derived from willow, only the salixin extract was found to exhibit similar antiviral activity. According to the authors, this suggests that the antiviral properties may be due to the combination of bioactive compounds in the tree bark.
The team plans to conduct further research to isolate and identify these compounds, as well as to study their mechanisms of action. This research could pave the way for the development of new antiviral drugs to treat a variety of viruses, including those that cause colds and flu. Professor Marjömäki and his team’s ongoing research aims to advance our understanding of these compounds and their possible use in antiviral therapy.
Previously Focus He wrote about whether the new Pirola coronavirus strain threatens another outbreak. The Covid-19 pandemic has long since ended, but the virus, which has mutated repeatedly, is still not waning, bringing a potentially dangerous variant to light once again.
Moreover Focus He wrote that post-Covid syndrome may not be related to the coronavirus at all. Researchers say long Covid may be caused by a completely different virus.
Important! This article is based on, and does not conflict with, the latest scientific and medical research. The text is for informational purposes only and does not contain medical advice. Be sure to consult a doctor to make a diagnosis.
Source: Focus
Ashley Fitzgerald is an accomplished journalist in the field of technology. She currently works as a writer at 24 news breaker. With a deep understanding of the latest technology developments, Ashley’s writing provides readers with insightful analysis and unique perspectives on the industry.